Lipegfilgrastim
Lonquex (lipegfilgrastim) is a protein pharmaceutical. Lipegfilgrastim was first approved as Lonquex on 2013-07-25. It has been approved in Europe to treat neutropenia.
| Trade Name | Lonquex |
|---|---|
| Common Name | Lipegfilgrastim |
| Indication | neutropenia |
| Drug Class | Pegylated compounds; colony-stimulating factors: granulocyte colony-stimulating factors (G-CSF) |
